Kuo, C. S., Tung, P., Huang, A. C., Wang, C., Chang, J. W., Liu, C., . . . Yang, C. (2021). A retrospective study of alectinib versus ceritinib in patients with advanced non–small-cell lung cancer of anaplastic lymphoma kinase fusion in whom crizotinib treatment failed. BMC Cancer.
Citación estilo ChicagoKuo, Chih-Hsi Scott, et al. "A Retrospective Study of Alectinib Versus Ceritinib in Patients With Advanced Non–small-cell Lung Cancer of Anaplastic Lymphoma Kinase Fusion in Whom Crizotinib Treatment Failed." BMC Cancer 2021.
Cita MLAKuo, Chih-Hsi Scott, et al. "A Retrospective Study of Alectinib Versus Ceritinib in Patients With Advanced Non–small-cell Lung Cancer of Anaplastic Lymphoma Kinase Fusion in Whom Crizotinib Treatment Failed." BMC Cancer 2021.